BIOMX INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.408 USD | -8.23% |
|
+21.43% | +45.71% |
| 04-18 | Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board | CI |
| 04-03 | Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024 |
Chart calendar BiomX Inc.
ffaabf77a9c5cda5e92d1ad.1qybTuuzGDcNyhnGfRZP2FSSEfRDlN_TVAGWSFCxJtA.seiqAInnSFo4vS-xKUcdnyLVdZcT_6-AC2rnDSHcbbaamfgpp9BKQ0m-KQ~2e0260dbadc9d5ccd91ee44440675127
Upcoming events on BiomX Inc.
Past events on BiomX Inc.
| 28/04/2024 11:00 | ECCMID Meeting - Poster No - P2546 |
| 03/04/2024 13:00 | Q4 2023 Earnings Call |
| 03/04/2024 11:30 | Q4 2023 Earnings Release |
| 06/03/2024 14:00 | Acquisition of Adaptive Phage Therapeutics, Inc. by BiomX, Inc. Call |
| 04/12/2023 17:00 | Investor Meeting - Key Opinion Leader |
| 29/11/2023 14:00 | BX004 Phase 2b/3 Study Results Call |
| 14/11/2023 11:30 | Q3 2023 Earnings Release |
| 03/11/2023 15:30 | North American Cystic Fibrosis Conference |
| 11/09/2023 12:00 | H.C. Wainwright Global Investment Conference |
| 10/09/2023 14:45 | European Respiratory Society International Congress - Abstract No: OA1534 |
| 28/08/2023 13:00 | Extraordinary Shareholders Meeting |
| 09/08/2023 13:00 | Q2 2023 Earnings Call |
| 09/08/2023 11:30 | Q2 2023 Earnings Release |
| 20/06/2023 13:00 | Annual General Meeting |
| 09/06/2023 16:00 | European Cystic Fibrosis Conference - P095 |
| 15/05/2023 13:00 | Q1 2023 Earnings Call |
| 15/05/2023 11:30 | Q1 2023 Earnings Release |
| 24/04/2023 13:00 | Extraordinary Shareholders Meeting |
| 29/03/2023 13:00 | Q4 2022 Earnings Call |
| 29/03/2023 11:30 | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,75 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -28,1 -30,1 6.72% | -32,9 -32,9 0.01% | -25,7 -27,4 6.2% | 0,00 -28,0 - | -33,4 |
|
EBIT Million USD | Released Forecast Spread | -22,2 -17,0 -30.63% | -30,3 -29,6 -2.4% | -35,5 -32,5 -9.06% | -27,2 -27,3 0.25% | -25,3 -26,8 5.4% | -36,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -20,6 -16,0 -28.52% | -30,1 -29,4 -2.33% | -36,2 -33,3 -8.66% | -28,3 -29,1 2.98% | -26,1 -27,6 5.12% | -37,3 |
|
Net income Million USD | Released Forecast Spread | -20,6 -16,0 -28.75% | -30,1 -29,4 -2.38% | -36,2 -33,3 -8.73% | -28,3 -29,1 2.76% | -26,2 -27,6 5.21% | -37,3 |
|
EPS USD | Released Forecast Spread | -3,66 -0,20 -1730% | -1,30 -1,26 -2.9% | -1,39 -1,30 -6.92% | -0,95 -0,98 2.56% | -0,51 -0,54 5.56% | -0,25 |
| Announcement Date | 26/03/20 | 31/03/21 | 30/03/22 | 29/03/23 | 03/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,75 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -14,7 -17,3 14.9% | -8,97 -8,30 -8.02% | -7,15 -9,40 23.89% | -6,69 -8,50 21.31% | -13,8 -16,3 15.07% | -6,17 -7,00 11.87% | -5,18 -6,90 24.93% | -6,21 -5,50 -12.87% | -5,86 -6,30 7.05% | -7,58 -5,90 -28.41% | -8,00 | -6,60 | -7,70 | -14,3 | -8,70 | -10,4 | |
|
EBIT Million USD | Released Forecast Spread | -15,8 -17,3 8.42% | -9,79 -6,52 -50.04% | -7,79 -8,34 6.69% | -7,32 -7,55 2.94% | -6,55 -6,32 -3.66% | -5,56 -6,55 15.11% | -6,21 -5,63 -10.31% | -6,07 -6,34 4.26% | -7,80 -5,91 -31.85% | -5,27 -5,51 4.37% | -9,57 | -10,5 | -9,89 | -8,98 | -7,73 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,7 -17,5 10.1% | -10,4 -7,53 -38.26% | -8,16 -9,07 10.08% | -7,47 -8,32 10.15% | -15,6 -17,0 8.04% | -6,77 -7,04 3.75% | -5,85 -7,06 17.2% | -6,36 -5,91 -7.47% | -6,40 -6,59 2.79% | -7,90 -6,28 -25.79% | -5,49 -6,93 20.77% | -8,31 | -9,45 | -14,9 | -9,57 | -9,96 | -7,97 |
|
Net income Million USD | Released Forecast Spread | -15,7 -17,5 10.07% | -10,5 -7,53 -38.94% | -8,17 -9,07 9.98% | -7,48 -8,32 10.04% | -15,7 -17,0 7.94% | -6,78 -7,04 3.63% | -5,89 -7,06 16.65% | -6,36 -5,90 -7.84% | -6,41 -6,64 3.5% | -7,91 -6,28 -25.92% | -5,49 -6,93 20.76% | -8,31 | -9,45 | -14,9 | -9,57 | -9,96 | -7,97 |
|
EPS USD | Released Forecast Spread | -0,65 -0,72 9.72% | -0,36 -0,28 -30.12% | -0,27 -0,30 10.99% | -0,25 -0,27 7.41% | -0,53 -0,57 7.02% | -0,23 -0,23 -1.1% | -0,20 -0,23 13.04% | -0,20 -0,18 -14.29% | -0,12 -0,15 17.24% | -0,13 -0,10 -30% | -0,08 -0,11 27.27% | -0,12 | -0,07 | -0,14 | -0,07 | -0,05 | -0,04 |
| Announcement Date | 16/08/21 | 30/03/22 | 11/05/22 | 10/08/22 | 10/08/22 | 09/11/22 | 29/03/23 | 15/05/23 | 09/08/23 | 14/11/23 | 03/04/24 | - | - | - | - | - | - |
More events
Past sector events for BiomX Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PHGE Stock
- Calendar BiomX Inc.
